Jnana Therapeutics, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 26
Rang # Quantité totale PI 55 999
Note d'activité PI 2,4/5.0    34
Rang # Activité PI 22 479
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

3 4
2 0
17 0
0
 
Dernier brevet 2025 - Bicyclic heteroaryl-containing p...
Premier brevet 2019 - Small molecules targeting mutant...
Dernière marque 2021 - JNANA THERAPEUTICS
Première marque 2021 - JNANA THERAPEUTICS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Naphthyl-containing piperidine inhibitors of slc6a19 function. Disclosed are naphthyl compounds c...
Invention Bicyclic heteroaryl-containing piperidine inhibitors of slc6a19 function. Disclosed are compounds...
Invention Piperidine inhibitor of slc6a19 function. Disclosed are a compound and pharmaceutically acceptabl...
2023 Invention Crystalline forms of a piperidine inhibitor of slc6a19 function. Disclosed are crystallines form ...
Invention Treating pku with spiro-substituted and other piperidine inhibitors of slc6a19 function. Disclose...
Invention Treating pku with correctors of mammalian slc6a19 function. Disclosed are compounds, compositions...
Invention Dosing regimen for treating pku with a piperidine inhibitor of slc6a19 function. Disclosed are me...
Invention Small molecule inhibitors of mammalian slc6a19 function. Disclosed are compounds, compositions, a...
2022 Invention Small molecule inhibitors of mammalian slc34a1 function. Disclosed are compounds, compositions, a...
Invention Small molecule inhibitors of mammalian slc6a19 function. Disclosed are compounds, compositions, ...
2021 Invention Small molecule correctors of mammalian slc6a8 function. Disclosed are compounds, compositions, an...
P/S Research, development and consultation related thereto in the medical, pharmaceutical research an...
P/S Pharmaceutical preparations that modulate historically undruggable targets across target classes,...
2020 Invention Reactive affinity probe-interaction discovery platform. Disclosed are methods, assays, and kits ...
Invention Reactive affinity probe-interaction discovery platform. Disclosed are methods, assays, and kits f...
2019 Invention Small molecules targeting mutant mammalian proteins. Disclosed are compounds, compositions, and ...
Invention Methods of treating creatine transporter deficiency. Disclosed are methods of treating creatine ...
Invention Small molecules targeting mutant mammalian proteins. Disclosed are compounds, compositions, and m...
Invention Methods of treating creatine transporter deficiency. Disclosed are methods of treating creatine t...